A citation-based method for searching scientific literature

Mohamad S Alabdaljabar, Khaled M Abdullah, Ali Almasood, Syed Salman Ali, Abdullah Ashmeg. Case Rep Med 2021
Times Cited: 2







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Euglycemic diabetic ketoacidosis: A missed diagnosis.
Prashant Nasa, Sandeep Chaudhary, Pavan Kumar Shrivastava, Aanchal Singh. World J Diabetes 2021
8
100


Dapagliflozin in Patients with Chronic Kidney Disease.
Hiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, Glenn M Chertow, Tom Greene, Fan-Fan Hou, Johannes F E Mann, John J V McMurray, Magnus Lindberg, Peter Rossing,[...]. N Engl J Med 2020
947
50

SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition.
Issei Tomita, Shinji Kume, Sho Sugahara, Norihisa Osawa, Kosuke Yamahara, Mako Yasuda-Yamahara, Naoko Takeda, Masami Chin-Kanasaki, Tatsuroh Kaneko, Eric Mayoux,[...]. Cell Metab 2020
81
50



Euglycaemic diabetic ketoacidosis.
J F Munro, I W Campbell, A C McCuish, L J Duncan. Br Med J 1973
163
50

A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery.
Deborah A Osafehinti, Ogochukwu J Okoli, Jocelyne G Karam. AACE Clin Case Rep 2020
2
50


Two cases of euglycemic diabetic ketoacidosis after bariatric surgery associated with sodium-glucose cotransporter-2 inhibitor use.
Erica A Amianda, Thomas S Gavigan, Toghrul Talishinskiy, Douglas R Ewing, Hans J Schmidt. Obes Surg 2021
1
100

Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
Suetonia C Palmer, Britta Tendal, Reem A Mustafa, Per Olav Vandvik, Sheyu Li, Qiukui Hao, David Tunnicliffe, Marinella Ruospo, Patrizia Natale, Valeria Saglimbene,[...]. BMJ 2021
134
50

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
50



Perioperative euglycemic diabetic ketoacidosis following use of SGLT-2 inhibitors after cardiac surgery.
João Paulo Jordão Pontes, Caroline Souto de Melo, Flávia Bittar Britto Arantes, Juan Thomaz Gabriel de Souza Ramos, Norma Sueli Pinheiro Módolo, Laís Helena Navarro E Lima. J Clin Anesth 2021
3
50

Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter 2 Inhibitor Use in Two Patients Undergoing Pancreatectomy.
Devon J Pace, Katerina Dukleska, Samantha Phillips, Vanessa Gleason, Charles J Yeo. J Pancreat Cancer 2018
12
50


Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study.
Antonios Douros, Lisa M Lix, Michael Fralick, Sophie Dell'Aniello, Baiju R Shah, Paul E Ronksley, Éric Tremblay, Nianping Hu, Silvia Alessi-Severini, Anat Fisher,[...]. Ann Intern Med 2020
38
50

SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
Ronald M Goldenberg, Lori D Berard, Alice Y Y Cheng, Jeremy D Gilbert, Subodh Verma, Vincent C Woo, Jean-François Yale. Clin Ther 2016
125
50

Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors.
Gian Paolo Fadini, Mayur Sarangdhar, Fabrizio De Ponti, Angelo Avogaro, Emanuel Raschi. BMJ Open Diabetes Res Care 2019
17
50



Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study.
Chintan V Dave, Sebastian Schneeweiss, Dae Kim, Michael Fralick, Angela Tong, Elisabetta Patorno. Ann Intern Med 2019
62
50

Euglycemic diabetic ketoacidosis following major vascular surgery is a new item on the differential for postoperative acidosis.
Clara M Gomez-Sanchez, Bian X Wu, Jeffrey E Gotts, Robert W Chang. J Vasc Surg Cases Innov Tech 2021
1
100



Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors.
Nicola Fleming, Peter Shane Hamblin, David Story, Elif I Ekinci. J Clin Endocrinol Metab 2020
12
50

SGLT-2 Inhibitors-a Culprit of Diabetic Ketoacidosis Postbariatric Surgery.
Qasim Zafar Iqbal, Danil Mishiyev, Muhammad Raphay Niazi, Zeeshan Zia, Saud Bin Abdul Sattar, Abdullah Jahanghir, Shahed Quyyumi. Case Rep Crit Care 2020
2
50

Sodium glucose-linked transport protein 2 inhibitors: An overview of genitourinary and perioperative implications.
Mohit Chandrashekar, Stuart Philip, Alexander Nesbitt, Andre Joshi, Marlon Perera. Int J Urol 2021
2
50


Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
50




Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers.
Manoj R Somagutta, Kuchalambal Agadi, Namrata Hange, Molly S Jain, Erkan Batti, Bernard O Emuze, Elizabeth O Amos-Arowoshegbe, Sorin Popescu, Saad Hanan, Varadha Retna Kumar,[...]. Cureus 2021
7
50

Euglycemic diabetic ketoacidosis: Etiologies, evaluation, and management.
Brit Long, Skyler Lentz, Alex Koyfman, Michael Gottlieb. Am J Emerg Med 2021
9
50

How far along are we in revealing the connection between metformin and colorectal cancer?
Maja Cigrovski Berkovic, Danko Mikulic, Ines Bilic-Curcic, Anna Mrzljak. World J Gastroenterol 2021
3
50

Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis.
Mohammed Faraz Rafey, Arslan Butt, Barry Coffey, Lisa Reddington, Aiden Devitt, David Lappin, Francis M Finucane. Endocrinol Diabetes Metab Case Rep 2019
14
50


Euglycemic Diabetic Ketoacidosis After Cardiac Surgery in a Patient Treated With Empagliflozin for Type 2 Diabetes Mellitus.
Peter Wohlrab, Matthias Kainz, Arno Schiferer, Bernhard Zapletal, Edda Tschernko. J Cardiothorac Vasc Anesth 2022
1
100

1
100

The Practice Guidelines for Primary Care of Acute Abdomen 2015.
Toshihiko Mayumi, Masahiro Yoshida, Susumu Tazuma, Akira Furukawa, Osamu Nishii, Kunihiro Shigematsu, Takeo Azuhata, Atsuo Itakura, Seiji Kamei, Hiroshi Kondo,[...]. Jpn J Radiol 2016
24
50

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.
Yehuda Handelsman, Robert R Henry, Zachary T Bloomgarden, Sam Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Ele Ferrannini, Vivian A Fonseca, Alan J Garber, George Grunberger,[...]. Endocr Pract 2016
183
50

[Position statement: surgery and diabetes mellitus (Update 2019)].
Peter Fasching, Joakim Huber, Martin Clodi, Heidemarie Abrahamian, Bernhard Ludvik. Wien Klin Wochenschr 2019
3
50

Geographical socioeconomic disadvantage is associated with adverse outcomes following major amputation in diabetic patients.
George Q Zhang, Joseph K Canner, Ahmed Kayssi, Christopher J Abularrage, Caitlin W Hicks. J Vasc Surg 2021
4
50

DIABETIC KETOACIDOSIS WITH AN ACUTE ABDOMEN AS A FIRST MANIFESTATION OF TYPE 1 DIABETES MELLITUS.
J Csomor, J Jirkovska, L Vedralova, S Solar, T Grega, P Urbanek, M Zavoral. Acta Endocrinol (Buchar) 2017
1
100

Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review.
Erasmia Sampani, Pantelis Sarafidis, Chrysostomos Dimitriadis, Efstratios Kasimatis, Dimitra Daikidou, Konstantinos Bantis, Alexios Papanikolaou, Aikaterini Papagianni. BMC Nephrol 2020
9
50

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann,[...]. N Engl J Med 2020
50

Abdominal pain in diabetic metabolic decompensation. Clinical significance.
I W Campbell, L J Duncan, J A Innes, A C MacCuish, J F Munro. JAMA 1975
43
50

Efficacy of Mannheim Peritonitis Index (MPI) Score in Patients with Secondary Peritonitis.
Muralidhar V A, Madhu C P, Sudhir S, Madhu Srinivasarangan. J Clin Diagn Res 2014
20
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.